Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Anagrelide (Xagrid) is a Platelet-reducing Agent. The mechanism of action of anagrelide is as a Phosphodiesterase 3 Inhibitor. The physiologic effect of anagrelide is by means of Decreased Platelet Production.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 15,500 |
5 mg | お問い合わせ | ¥ 36,000 |
10 mg | お問い合わせ | ¥ 51,000 |
25 mg | お問い合わせ | ¥ 79,500 |
50 mg | お問い合わせ | ¥ 122,500 |
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 22,500 |
説明 | Anagrelide (Xagrid) is a Platelet-reducing Agent. The mechanism of action of anagrelide is as a Phosphodiesterase 3 Inhibitor. The physiologic effect of anagrelide is by means of Decreased Platelet Production. |
別名 | Anagrelida, Xagrid, Anagrelidum |
分子量 | 256.09 |
分子式 | C10H7Cl2N3O |
CAS No. | 68475-42-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mM
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Anagrelide 68475-42-3 Metabolism PDE phosphodiesterase Anagrelida inhibit imidazoquinazoline myeloproliferative disorders megakaryocyte Xagrid haematopoiesis Inhibitor Anagrelidum antithrombopoietic Phosphodiesterase (PDE) platelet production inhibitor